c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Anticancer Research

• Publication date

  1990-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2164348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic changes in the pathogenesis of lung cancer.

  1994cited by this paper
• ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.

  1989cited by this paper
• Amplification and expression of different myc‐family genes in a tumor specimen and 3 cell lines derived from one small‐cell lung cancer patient during longitudinal follow‐up

  1989cited by this paper
• Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.

  1989cited by this paper
• Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.

  1989cited by this paper
• The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.

  1988cited by this paper
• Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

  1987cited by this paper
• A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.

  1987cited by this paper
• Abnormalities of protooncogenes in non‐small cell lung cancer. Correlations with tumor type and clinical characteristics

  1987cited by this paper
• Loss of genes on the short arm of chromosome 11 in human lung carcinomas.

  1987cited by this paper
• Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

  1987cited by this paper
• Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.

  1987cited by this paper
• Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung.

  1987cited by this paper
• myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

  1987cited by this paper
• The myc oncogene: its role in transformation and differentiation.

  1986cited by this paper
• Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.

  1986cited by this paper
• The tumour promoter 12-O-tetradecanoylphorbol-13-acetate increases the activities of some peroxisome-associated enzymes in in vitro cell culture.

  1986cited by this paper
• Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins.

  1985cited by this paper
• Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

  1985cited by this paper
• Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.

  1985cited by this paper
• Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.

  1985cited by this paper
• Amplification and expression of the c-myc oncogene in human lung cancer cell lines

  1983cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

  1976cited by this paper

• Targets of Wnt/ß-Catenin Transcription in Penile Carcinoma

  2015cites this paper
• Relationship of immunohistochemical biomarker expression and lymph node involvement in patients undergoing surgical treatment of NSCLC with long-term follow-up

  2014cites this paper
• Expression of cm yc , bcl-2 and p 53 Proteins in A denocarcinom as of Lung

  2010cites this paper
• Expression of C aspase-3 and cm yc in N on-Sm all C ell Lung C ancer

  2010cites this paper
• [Molecular aspects of head and neck, and lung cancer oncogenesis].

  2009cites this paper
• Abnormal expression of c-Myc in human bronchial epithelial cells malignantly transformed by anti-BPDE

  2008cites this paper
• Gene therapy for lung cancer

  2006cites this paper
• Gene therapy for lung cancer.

  2006cites this paper
• Chemoprevention in lung carcinogenesis--an overview.

  2005cites this paper
• Chemoprevention in lung carcinogenesis – An overview

  2005cites this paper
• Chemoprevention of lung cancer.

  2005cites this paper
• D epartm ent of Pathology, St V incent's H ospital, C atholic U niversity, Suwon, K orea

  2004cites this paper
• Expression of caspase-3 and c-myc in non-small cell lung cancer.

  2004cites this paper
• The expression of c-myc, bcl-2 and p53 proteins in adenocarcinomas of lung.

  2004cites this paper
• Chemoprevention of Cancer

  2004influential citation
• Chemoprevention of lung cancer.

  2003cites this paper
• Prognostic factors in non-small cell lung carcinoma.

  2002cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• [Biomarkers of carcinogenesis of the upper and lower airway epithelium and the role of chemoprevention].

  2001cites this paper
• Molecular events in bronchogenic carcinoma and their implications for therapy.

  2000cites this paper
• c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.

  2000cites this paper
• The Role of Biomarkers in Detecting Early Changes Relating to Exposure to Occupational Carcinogens

  1996cites this paper
• The molecular epidemiology of oncoproteins.

  1996cites this paper
• Expression of ras p21 and myc p64 oncoproteins in imprint smears of lung-cancer.

  1995cites this paper
• Prognostic Factors in Small Cell Lung Cancer.

  1995cites this paper
• Genetics of murine lung tumors.

  1995cites this paper
• Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.

  1995cites this paper
• Prognostic factors in lung cancer: tables and comments.

  1994cites this paper
• [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products].

  1994cites this paper
• Prognostic ffactors iin llung c cancer: T Tables a and C Comments

  1994cites this paper
• The role of the pathologist in the clinical management of lung cancer in the 90's

  1993cites this paper
• Oncogenes and onco-suppressor genes in lung cancer.

  1993cites this paper
• Quantitation of biological tumor markers (p53, c‐myc, Ki‐67 and DNA ploidy) by multiparameter flow cytometry in non‐small‐cell lung cancer

  1992cites this paper
• Pathology of pulmonary endocrine neoplasms

  1992cites this paper
• Role of Peptide Growth Factors in Asbestos‐Related Human Lung Cancer

  1991cites this paper
• Studies of the geographic patterns of c‐myc expression in bone marrow

  1991cites this paper